We used 2 types of assays for the initial viral screen, immunologic assays to identify antibodies and reverse transcription polymerase chain reaction (RT-PCR) to detect the viral genome.
The activity of these compounds as inhibitors of p53 MDM2 interaction was investigated using a yeast phenotypic assay, herein developed for the initial screening.
(A simplified version of this assay was employed for the initial measurements of Oct4 templates only.
The present study showed that 21.3% of the patients with undetectable HCV RNA by qualitative Amplicor assay were positive for TaqMan assay within the initial 12 weeks during PEG-IFN plus RBV treatment.
In the second experiment, the initial number of target molecules for each of the 95 assays was 100 per reaction, and only for one assay (IGF2BP3) the initial amount of target molecules was varied from 100 to 10 per reaction.
If the index sample tested reactive, it was repeated in duplicate using the same MHA-TP assay that was employed for the initial screening.
For dephosphorylation assays, after the initial phosphorylation reaction described above, the DegS/YbdM and DegS/YabT reaction mixtures were desalted on a PD-10 column (to remove the ATP), lyophilized and resuspended in the identical reaction mixture as before, but without ATP, and incubated 2 hours at 37°C.
For the initial assay in 2012, we classified test results for all participants into 3 groups: definite negative (mean fluorescence intensity of CD69 above control; range 0%5.9%%), possibly negative (intermediate mean fluorescence intensity; range 6.1%8.1%%), and definite positive (mean fluorescence intensity; range 9.4%33.1%%).
Pre-amplified PCR products were diluted 1 10 (North Bay colonies) or 1 10 (Ned's Beach colonies) in deionised sterile water prior to PCR-DGGE and qPCR analysis (these differences were due to shortages of DNA template solutions from the Ned's Beach colonies, which were used for the initial assay development and optimization process).
